Related Experiment Video
Updated: Jan 23, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Ambivalence about the selection of cardiovascular risk stratification tools: Evidence in a type 1 diabetes population
Ticiane G Bovi1, Denise Engelbrecht Zantut-Wittmann1, Maria Cândida Ribeiro Parisi1
1Division of Endocrinology, Department of Clinical Medicine, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, CP:13083-887, SP, Brazil.
Insights
Cardiovascular risk calculators for Type 1 Diabetes show significant differences in patient stratification. The CRSC tool identified most patients as high risk, impacting statin eligibility recommendations compared to the Steno tool.
Area of Science:
- Endocrinology
- Cardiology
- Diabetology
Background:
- Cardiovascular disease (CVD) is a leading cause of death in people with diabetes.
- Limited tools exist for assessing cardiovascular risk (CVR) in Type 1 Diabetes (T1D) patients.
- Existing CVR tools show divergence in risk stratification and treatment recommendations.
Purpose of the Study:
- To compare the risk stratification of two CVR tools in T1D patients.
- To evaluate the impact of differing risk assessments on statin eligibility.
- To identify discrepancies between the Steno Type 1 Risk Engine and the Cardiovascular Risk Stratification Calculator (CRSC).
Main Methods:
- A cross-sectional study involving 104 T1D patients (aged 18-40).
- Utilized the Steno Type 1 Risk Engine and the CRSC for 10-year cardiovascular event risk assessment.
- Analyzed differences in risk stratification and statin eligibility between the two tools.
Main Results:
- Significant divergence in CVR stratification between the Steno and CRSC tools.
- CRSC classified 65.82% of patients as intermediate or high risk, whereas Steno classified them as low risk.
- Discrepancies in statin eligibility were noted based on the risk stratification from each tool.
Conclusions:
- The Steno and CRSC tools provide divergent CVR assessments for T1D patients.
- CRSC identified a majority of the sample as high risk, leading to different statin prescription recommendations compared to Steno.
- The choice of CVR tool significantly impacts clinical decisions, particularly regarding statin use in T1D.
Background:
Cardiovascular disease (CVD) is one of the leading causes of death among people with diabetes, however, despite the increasing incidence of CVD, there are few tools for evaluating Cardiovascular Risk (CVR) in the population of patients with Type 1 Diabetes (T1D), with the existing ones diverging in the stratification of risk and in the suggestions for therapeutic conduct.
Methods:
A cross-sectional study was carried out with 104 participants diagnosed with T1D, aged 18-40, attending specialized services. The Steno Type 1 Risk Engine and the Cardiovascular Risk Stratification Calculator (CRSC) were used to assess the risk of a cardiovascular event over a 10-year period.
Findings:
Of the total sample selected, 62% were female, with a median age of 32 years (IQ 24; 43). There was a large difference between the stratification of CVR between the calculators, and 65.82% of the patients classified as low risk for CVD according to the Steno were identified as intermediate (30, 38.00%) and high risk (35.44%) by the CRSC. The analysis also highlighted a great difference in eligibility for statin use according to the risk stratification of the tools.
Conclusion:
The CRSC and Steno tools evaluated and stratified the CVR of the same population with T1D, with there being divergence of the results. It was found that the CRSC tool classified the majority of the sample as high risk. Due to this result, the eligibility to use statins, which is one of the applications of these tools, showed great differences, with the Steno tool presenting less aggressive provisions regarding the prescription of statins in patients with type 1 DM.
More Related Videos
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Related Concept Videos
Types of Selection
The Evidence for Evolution
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Conservation of Small Populations
What is Population Genetics?